의료 관련 주식
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4002 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 2.75 USD | +3.38% | +8.27% | -8.64% | -68.64% | 71.33 M USD | ||
| 4003 |  ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 1.50 USD | -1.96% | +26.05% | +13.64% | -38.52% | 71.09 M USD | ||
| 4008 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.55 USD | +1.85% | 0.00% | -29.49% | -52.59% | 70.13 M USD | ||
| 4012 |  CTOR Citius Oncology, Inc. - Common Stock | 0.75 USD | -1.32% | -10.71% | -22.68% | -35.34% | 69.74 M USD | ||
| 4016 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.73 USD | -6.41% | -18.89% | -29.81% | -59.67% | 69.42 M USD | ||
| 4017 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.14 USD | +0.88% | -3.39% | -21.38% | -45.19% | 69.34 M USD | ||
| 4023 |  PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.29 USD | +4.03% | -13.42% | -9.79% | -7.19% | 68.96 M USD | ||
| 4033 |  CSBR Champions Oncology, Inc. - Common Stock | 4.79 USD | -0.42% | -2.44% | -2.04% | -25.62% | 66.67 M USD | ||
| 4036 |  XBIT XBiotech Inc. - Common Stock | 2.16 USD | 0.00% | -2.26% | -0.46% | -14.29% | 65.85 M USD | ||
| 4038 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.13 USD | +0.89% | -0.88% | -0.88% | -51.08% | 65.81 M USD | ||
| 4042 |  HYFT MindWalk Holdings Corp. - Common Stock | 1.40 USD | +2.19% | -2.78% | +21.74% | -14.63% | 65.40 M USD | ||
| 4047 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 3.78 USD | -1.31% | -13.50% | -19.57% | -37.21% | 64.94 M USD | ||
| 4048 |  OSTX OS Therapies Incorporated Common Stock | 1.40 USD | 0.00% | -14.11% | -23.08% | +21.74% | 64.58 M USD | ||
| 4053 |  CING Cingulate Inc. - Common Stock | 4.39 USD | -3.94% | -9.86% | -15.09% | -28.73% | 63.84 M USD | ||
| 4054 |  MBOT Microbot Medical Inc. - Common Stock | 0.95 USD | -4.04% | -12.04% | -34.48% | -66.07% | 63.81 M USD | ||
| 4056 |  FBIO Fortress Biotech, Inc. - Common Stock | 1.91 USD | +0.53% | -9.91% | -23.29% | -29.78% | 63.70 M USD | ||
| 4066 |  BMEA Biomea Fusion, Inc. - Common Stock | 0.84 USD | +1.20% | -39.13% | -52.81% | -47.50% | 60.89 M USD | ||
| 4068 |  PLRX Pliant Therapeutics, Inc. - Common Stock | 0.97 USD | +10.23% | -2.02% | -11.01% | -41.21% | 60.06 M USD | ||
| 4081 |  GANX Gain Therapeutics, Inc. - Common Stock | 1.33 USD | +0.76% | -17.39% | -24.86% | -26.11% | 58.05 M USD | ||
| 4087 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 0.91 USD | 0.00% | +4.60% | -26.02% | -49.44% | 57.31 M USD |
뉴스 의료 관련 주식
UBS, 솔리드 바이오사이언스 투자의견 ‘매수’로 신규 개시···목표주가 20달러 제시
매크로제닉스, 진행성 고형암 환자 대상 비공개 표적 항체-약물 접합체 MGC030의 1상 임상시험에서 첫 환자 투여
목요일 장중 변동한 12개 헬스케어 주식
다이애딕 인터내셔널 13G 공시: 엠퍼리 에셋 매니지먼트, 9월 30일 기준 8.35% 지분 보유 보고
뉴라시스, 의료 정책 적용 범위가 2,600만 명 이상의 의료 보험 가입자에게 확대되었다고 발표
에데사 바이오테크, 백반증 치료제 EB06의 2상 임상시험을 위한 신약 임상시험계획(IND) 신청에 대해 FDA 승인 획득
렉사리아 바이오사이언스, 디하이드라테크-CBD 조성물 및 디하이드라테크-세마글루타이드 모두 평가한 동물실험 GLP-1-A26-1 결과 발표···아쉽게도 뇌 조직 내 DHT-SEMA 농도는 본 연구에 사용된 생물학적 분석의 정량 하한선 이하 수준
Gainers 의료 관련 주식
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Losers 의료 관련 주식
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |